Results 151 to 160 of about 1,055,250 (236)

Impact of Multiple Low-Anticholinergic Drugs on Older Inpatients: Insights From the J-HAC Study. [PDF]

Geriatr Gerontol Int
Koujiya E, Takeshita Y, Yakabe M, Mizokami F, Umegaki H, Takeya Y.   +5 more
europepmc   +1 more source

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis. [PDF]

Age Ageing, 2020
Pieper NT, Grossi CM, Chan WY, Loke YK, Savva GM, Haroulis C, Steel N, Fox C, Maidment ID, Arthur AJ, Myint PK, Smith TO, Robinson L, Matthews FE, Brayne C, Richardson K.   +15 more
europepmc   +1 more source

National Drugs Advisory Board annual report and accounts, 1994

, 1994
The National Drugs Advisory Board was established by the Minister for Health in 1966 by the National Drugs Advisory Board (Establishment) Order 1966 (5.1. No. 163 of 1966) under the Health (Corporate Bodies) Act 1961.
National Drugs Advisory Board (NDAB)
core  

Anticholinergic drugs and dementia risk: Using stem cell-based studies to complement pharmacoepidemiology. [PDF]

Alzheimers Dement (N Y)
Schwarze-Taufiq TA, Pranoto IKA, Hui K, Kinoshita C, Yu O, Crane PK, Gray SL, Young JE.   +7 more
europepmc   +1 more source

Temporal Trends in the Use of Anticholinergic Drugs Among Older People Living in Long-Term Care Facilities in Helsinki. [PDF]

Drugs Aging, 2020
Aalto UL, Roitto HM, Finne-Soveri H, Kautiainen H, Pitkälä KH.   +4 more
europepmc   +1 more source

Gastric secretion and anticholinergic drugs

Journal of British Surgery, 1968
D T, Caridis, G, Smith
openaire   +2 more sources

Research Letter: Anticholinergic Drugs and the Gallbladder -A Neglected Effect? [PDF]

Perm J, 2017
Friedman GD, Achacoso N, Habel LA.
europepmc   +1 more source

Anticholinergic drugs and clinical outcomes in older people with and without dementia- A systematic Review

Bishara D, Davis K, Mueller C, Dzahini O, Funnell N, Sauer J, Harwood D, Taylor D, Stewart R.   +8 more
europepmc   +1 more source